Patent · US Active

Topical montelukast for treatment of atopic dermatitis

US10548837B1 · kind B1 · utility

4Cited by

0References

7Claims

0Family size

Assignee

TARO PHARMACEUTICAL INDUSTRIES LTD. · IL

Inventors

Avi Avramoff · Haifa, IL
Helena Shifrin · Rehovot, IL
Irena Oleinik · Carmiel, IL
Ron SCHLINGER · Haifa, IL
Tzviel SHESKIN · Haifa, IL
Vered Rosenberger · Jerusalem, IL

Key dates

Filing date	May 3, 2017
Grant date	Feb 4, 2020
Priority date	—
Expiry date	May 3, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A topical formulation comprising Montelukast or a pharmaceutically acceptable salt thereof, a gelling agent and water for the treatment of atopic dermatitis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.